一例高胰岛素性低血糖患者中68Ga-DOTATATE与68Ga-Exendin PET/CT偶然发现并表征两种不同病理并最终诊断MEN-1
本文报告一名22岁男性,因过去1年行为改变、72小时饥饿试验阳性及腹部CT发现胰腺病变而疑诊高胰岛素性低血糖,转诊行68Ga-Exendin-4 PET/CT。68Ga-Exendin PET/CT显示胰腺病变局灶性摄取,68Ga-DOTATATE PET/CT未见胰腺病变摄取,但显示甲状腺后方软组织肿块表达生长抑素受体。最终证实甲状旁腺腺瘤和甲状旁腺功能亢进,基因检测阳性确诊MEN-1综合征。
要点
- 68Ga-Exendin PET/CT显示胰腺病变局灶性摄取,68Ga-DOTATATE PET/CT未见该胰腺病变摄取。
- 68Ga-DOTATATE PET/CT显示甲状腺后方软组织肿块生长抑素受体表达,最终证实甲状旁腺腺瘤和甲状旁腺功能亢进。
- 基因检测阳性确诊MEN-1综合征,多示踪剂PET有助于鉴别MEN-1中两种不同病理。
核心结论
- 本报告说明多示踪剂PET在解析多发性内分泌腺瘤1型(MEN-1)中两种不同病理方面具有互补作用。
研究设计与样本
- 本文为病例报告,报告一名22岁男性,有过去1年行为改变史,基于72小时饥饿试验阳性和腹部CT显示胰腺病变而疑诊高胰岛素性低血糖。
主要发现
- 68Ga-Exendin PET/CT显示胰腺病变局灶性摄取,而68Ga-DOTATATE PET/CT未见胰腺病变摄取。
- 68Ga-DOTATATE PET/CT显示甲状腺后方软组织肿块表达生长抑素受体(SSTR)。
- 最终证实甲状旁腺腺瘤和甲状旁腺功能亢进,基因检测阳性确诊MEN-1综合征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The complementary role of multi-tracer PET in deciphering 2 different pathologies in multiple endocrine neoplasia 1 (MEN-1) is illustrated in this report. A 22-year-old man, with a history of altered behavior over the past 1 year and suspected to have hyperinsulinemic hypoglycemia based on a positive 72-hour fasting test and CT abdomen revealing a lesion in the pancreas, was referred for 68 Ga-Exendin-4 PET/CT. The 68 Ga-Exendin PET/CT revealed focal uptake in the pancreatic lesion, and 68 Ga-DOTATATE PET/CT did not show any avidity in the pancreatic lesion; however, it demonstrated somatostatin receptor (SSTR) expression in a soft tissue mass, just posterior to the thyroid. Parathyroid adenoma and hyperparathyroidism were finally proven, and genetic testing was done, which came positive for the diagnosis of MEN-1 syndrome.
引用
- Barapatre R, Verma P, Lila AR, et al. Serendipitous Discovery and Characterization of Two Different Pathologies on 68 Ga-DOTATATE and 68 Ga-Exendin PET/CT in a Patient With Hyperinsulinemic Hypoglycemia Leading to Diagnosis of MEN-1. Clin Nucl Med. 2025. PMID: 40096661. doi:10.1097/RLU.0000000000005840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。